Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:41 UTC |
---|
HMDB ID | HMDB0000291 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Vanillylmandelic acid |
---|
Description | Vanillylmandelic acid, also known as vanillylmandelate or VMA, belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. Vanillylmandelic acid is a sweet and vanilla tasting compound. Vanillylmandelic acid (VMA) is a chemical intermediate in the synthesis of artificial vanilla flavorings and is an end-stage metabolite of the catecholamines (dopamine, epinephrine, and norepinephrine). Vanillylmandelic acid exists in all living organisms, ranging from bacteria to plants to humans. Within humans, vanillylmandelic acid participates in a number of enzymatic reactions. In particular, vanillylmandelic acid can be biosynthesized from 3-methoxy-4-hydroxyphenylglycolaldehyde through its interaction with the enzyme aldehyde dehydrogenase. In addition, vanillylmandelic acid and pyrocatechol can be biosynthesized from 3,4-dihydroxymandelic acid and guaiacol through the action of the enzyme catechol O-methyltransferase. Urinary VMA is elevated in patients with tumors that secrete catecholamines. Urinary VMA tests may also be used to diagnose neuroblastomas, and to monitor treatment of these conditions. VMA urinalysis tests can be used to diagnose an adrenal gland tumor called pheochromocytoma, a tumor of catecholamine-secreting chromaffin cells. Vanillylmandelic acid (VMA) is produced in the liver and is a major product of norepinephrine and epinephrine metabolism excreted in the urine. |
---|
Structure | COC1=C(O)C=CC(=C1)[C@H](O)C(O)=O InChI=1S/C9H10O5/c1-14-7-4-5(2-3-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13)/t8-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Vanillylmandelate | Generator | (4-Hydroxy-3-methoxyphenyl)glycolate | HMDB | (4-Hydroxy-3-methoxyphenyl)glycolic acid | HMDB | 3-Methoxy-4-hydroxy-mandelic acid | HMDB | 3-Methoxy-4-hydroxymandelate | HMDB | 3-Methoxy-4-hydroxymandelic acid | HMDB | 3-Methoxy-4-hydroxyphenylhydroxyacetate | HMDB | 3-Methoxy-4-hydroxyphenylhydroxyacetic acid | HMDB | 4'-Hydroxy-3'-methoxymandelate | HMDB | 4'-Hydroxy-3'-methoxymandelic acid | HMDB | 4-Hydroxy 3-methoxymandelic acid | HMDB | 4-Hydroxy-3-methoxy-DL-mandelate | HMDB | 4-Hydroxy-3-methoxy-DL-mandelic acid | HMDB | 4-Hydroxy-3-methoxy-mandelate | HMDB | 4-Hydroxy-3-methoxy-mandelic acid | HMDB | 4-Hydroxy-3-methoxymandelate | HMDB | 4-Hydroxy-3-methoxymandelic acid | HMDB | DL-3-Methoxy-4-hydroxymandelate | HMDB | DL-3-Methoxy-4-hydroxymandelic acid | HMDB | DL-4-Hydroxy-3-methoxymandelate | HMDB | DL-4-Hydroxy-3-methoxymandelic acid | HMDB | DL-Vanillomandelate | HMDB | DL-Vanillomandelic acid | HMDB | DL-Vanillylmandelate | HMDB | DL-Vanillylmandelic acid | HMDB | HMMA | HMDB | Hydroxymethoxymandelic acid | HMDB | Lopac-H-0131 | HMDB | Vainillylmandelic acid | HMDB | Vanillinmandelate | HMDB | Vanillinmandelic acid | HMDB | Vanillomandelate | HMDB | Vanillomandelic acid | HMDB | Vanillyl-mandelic acid | HMDB | Vanillylmandellic acid | HMDB | Vanillymandelic acid | HMDB | Vanilmandelate | HMDB | Vanilmandelic acid | HMDB | Vanilylmandelic acid | HMDB | Vanyl-mandelic acid | HMDB | Vanylmandelic acid | HMDB | VMA | HMDB | 2-Phenyllactic acid | HMDB | VMA CPD | HMDB | Atrolactic acid | HMDB | Atrolactic acid monosodium salt, (S)-isomer | HMDB | Atrolactic acid, (+-)-isomer | HMDB | Hydroxymethylmandelic acid | HMDB | (+)-4-Hydroxy-3-methoxymandelic acid | HMDB | (+)-Vanilmandelic acid | HMDB | (2S)-2-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetic acid | HMDB | (S)-4-Hydroxy-3-methoxymandelic acid | HMDB | (alphaS)-alpha,4-Dihydroxy-3-methoxybenzeneacetic acid | HMDB | (αS)-α,4-Dihydroxy-3-methoxybenzeneacetic acid | HMDB | 2-(4'-Hydroxy-3'-methoxyphenyl)-2-hydroxyethanoic acid | HMDB | 2-(4’-Hydroxy-3’-methoxyphenyl)-2-hydroxyethanoic acid | HMDB | 2-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetic acid | HMDB | 4’-Hydroxy-3’-methoxymandelic acid | HMDB | L-(+)-3-Methoxy-4-hydroxymandelic acid | HMDB | Vanillylmandelic acid | HMDB | alpha,4-Dihydroxy-3-methoxybenzeneacetic acid | HMDB | α,4-Dihydroxy-3-methoxybenzeneacetic acid | HMDB |
|
---|
Chemical Formula | C9H10O5 |
---|
Average Molecular Weight | 198.1727 |
---|
Monoisotopic Molecular Weight | 198.05282343 |
---|
IUPAC Name | (2S)-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetic acid |
---|
Traditional Name | (S)-hydroxy(4-hydroxy-3-methoxyphenyl)acetic acid |
---|
CAS Registry Number | 13244-77-4 |
---|
SMILES | COC1=C(O)C=CC(=C1)[C@H](O)C(O)=O |
---|
InChI Identifier | InChI=1S/C9H10O5/c1-14-7-4-5(2-3-6(7)10)8(11)9(12)13/h2-4,8,10-11H,1H3,(H,12,13)/t8-/m0/s1 |
---|
InChI Key | CGQCWMIAEPEHNQ-QMMMGPOBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as methoxyphenols. Methoxyphenols are compounds containing a methoxy group attached to the benzene ring of a phenol moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Phenols |
---|
Sub Class | Methoxyphenols |
---|
Direct Parent | Methoxyphenols |
---|
Alternative Parents | |
---|
Substituents | - Methoxyphenol
- Phenoxy compound
- Anisole
- Methoxybenzene
- Phenol ether
- 1-hydroxy-2-unsubstituted benzenoid
- Alkyl aryl ether
- Alpha-hydroxy acid
- Monocyclic benzene moiety
- Hydroxy acid
- Secondary alcohol
- Monocarboxylic acid or derivatives
- Ether
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Alcohol
- Carbonyl group
- Organic oxygen compound
- Organic oxide
- Organooxygen compound
- Aromatic alcohol
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 132 - 134 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Vanillylmandelic acid,1TMS,isomer #1 | COC1=CC([C@H](O)C(=O)O)=CC=C1O[Si](C)(C)C | 1885.0 | Semi standard non polar | 33892256 | Vanillylmandelic acid,1TMS,isomer #2 | COC1=CC([C@H](O[Si](C)(C)C)C(=O)O)=CC=C1O | 1852.5 | Semi standard non polar | 33892256 | Vanillylmandelic acid,1TMS,isomer #3 | COC1=CC([C@H](O)C(=O)O[Si](C)(C)C)=CC=C1O | 1814.7 | Semi standard non polar | 33892256 | Vanillylmandelic acid,2TMS,isomer #1 | COC1=CC([C@H](O[Si](C)(C)C)C(=O)O)=CC=C1O[Si](C)(C)C | 1884.8 | Semi standard non polar | 33892256 | Vanillylmandelic acid,2TMS,isomer #2 | COC1=CC([C@H](O)C(=O)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 1880.9 | Semi standard non polar | 33892256 | Vanillylmandelic acid,2TMS,isomer #3 | COC1=CC([C@H](O[Si](C)(C)C)C(=O)O[Si](C)(C)C)=CC=C1O | 1897.2 | Semi standard non polar | 33892256 | Vanillylmandelic acid,3TMS,isomer #1 | COC1=CC([C@H](O[Si](C)(C)C)C(=O)O[Si](C)(C)C)=CC=C1O[Si](C)(C)C | 1912.8 | Semi standard non polar | 33892256 | Vanillylmandelic acid,1TBDMS,isomer #1 | COC1=CC([C@H](O)C(=O)O)=CC=C1O[Si](C)(C)C(C)(C)C | 2170.0 | Semi standard non polar | 33892256 | Vanillylmandelic acid,1TBDMS,isomer #2 | COC1=CC([C@H](O[Si](C)(C)C(C)(C)C)C(=O)O)=CC=C1O | 2138.0 | Semi standard non polar | 33892256 | Vanillylmandelic acid,1TBDMS,isomer #3 | COC1=CC([C@H](O)C(=O)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2073.1 | Semi standard non polar | 33892256 | Vanillylmandelic acid,2TBDMS,isomer #1 | COC1=CC([C@H](O[Si](C)(C)C(C)(C)C)C(=O)O)=CC=C1O[Si](C)(C)C(C)(C)C | 2416.3 | Semi standard non polar | 33892256 | Vanillylmandelic acid,2TBDMS,isomer #2 | COC1=CC([C@H](O)C(=O)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2359.0 | Semi standard non polar | 33892256 | Vanillylmandelic acid,2TBDMS,isomer #3 | COC1=CC([C@H](O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)=CC=C1O | 2371.1 | Semi standard non polar | 33892256 | Vanillylmandelic acid,3TBDMS,isomer #1 | COC1=CC([C@H](O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C)=CC=C1O[Si](C)(C)C(C)(C)C | 2582.2 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0udi-3900000000-97b85fd5a9736a5d5eb0 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (3 TMS) - 70eV, Positive | splash10-009t-7396100000-b5450c24921a68f5f6b3 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Vanillylmandelic acid GC-MS (TBDMS_3_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Vanillylmandelic acid Quattro_QQQ 10V, Negative-QTOF (Annotated) | splash10-000b-0900000000-1e2dedd8e81249787b29 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Vanillylmandelic acid Quattro_QQQ 25V, Negative-QTOF (Annotated) | splash10-000i-0900000000-3d2cd918dc6b76dfba3f | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Vanillylmandelic acid Quattro_QQQ 40V, Negative-QTOF (Annotated) | splash10-000i-2900000000-b543807e43e5091abb53 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Vanillylmandelic acid 40V, Negative-QTOF | splash10-000i-1900000000-1c88ce4d32680e3379de | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Vanillylmandelic acid 10V, Negative-QTOF | splash10-000i-0900000000-30e1c8cb4fa5443c687e | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Vanillylmandelic acid 20V, Negative-QTOF | splash10-000i-0900000000-c4c762f850d22fee6281 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 10V, Negative-QTOF | splash10-0f6t-0900000000-1308d37a2313f5479365 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 20V, Negative-QTOF | splash10-0fmj-0900000000-bcdff30bcec2389ffef6 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 40V, Negative-QTOF | splash10-0ab9-3900000000-cd2db271b5a0926adfeb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 10V, Negative-QTOF | splash10-00dj-9700000000-2c212037a037fcd229d0 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 20V, Negative-QTOF | splash10-0kg9-1900000000-81b2ab77bf3382c9f5de | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 40V, Negative-QTOF | splash10-0002-4900000000-e3b77a4d29235649ecce | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 10V, Positive-QTOF | splash10-0f8a-0900000000-04d80bfab4984d07e479 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 20V, Positive-QTOF | splash10-0udi-0900000000-23d4830296b7ea07f0d5 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 40V, Positive-QTOF | splash10-0fki-5900000000-9b9364530caece4b6c12 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 10V, Positive-QTOF | splash10-0f7t-0900000000-ac32d971a0581e8b6cb6 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 20V, Positive-QTOF | splash10-000i-0900000000-bce2f2854f319781df10 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Vanillylmandelic acid 40V, Positive-QTOF | splash10-0umi-9700000000-311af8dc825e2dd02614 | 2021-09-25 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adrenal Gland
- Epidermis
- Thyroid Gland
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.035 +/- 0.008 uM | Adult (>18 years old) | Male | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 4.906 +/- 1.769 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 5.0776 +/- 1.712 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 5.135 +/- 1.826 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 6.2 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 1.585 +/- 1.095 umol/mmol creatinine | Adult (>18 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 3.67 +/- 2.12 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 7.758 +/- 2.944 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 13.24 +/- 5.3 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 5.38 +/- 1.83 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 4.18 +/- 1.55 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 6.19 +/- 2.014 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | Urine | Detected and Quantified | 6.22 +/- 2.32 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 10.0 (0.3-20.0) umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 3.22-9.08 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 5.68 +/- 2.19 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 5.93 +/- 3.016 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 1.6-2.2 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | Urine | Detected and Quantified | 2.3 (1.0-3.4) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.2 +/- 0.5 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.300-19.700 umol/mmol creatinine | Children (1-13 years old) | Female | Normal | | details | Urine | Detected and Quantified | 1.1-1.7 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 0.5-7.6 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | Urine | Detected and Quantified | 12.5 (3.7-21.8) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 12.4 (11.6-25.9) umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 6.5 (1.3-11.5) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 6.5 (2.9-13.0) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | 5.2 (2.5-16.1) umol/mmol creatinine | Children (1-13 years old) | Both | Normal | | details | Urine | Detected and Quantified | <=3.289 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 1.6 (0.6-2.8) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 9.128 +/- 4.450 umol/mmol creatinine | Children (1-13 years old) | Both | Phenylketonuria | | details | Urine | Detected and Quantified | 7.586 +/- 3.852 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 7.332 +/- 3.711 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details | Urine | Detected and Quantified | 0.15 (0.00-0.30) umol/mmol creatinine | Infant (0-1 year old) | Male | Aromatic L-amino acid decarboxylase deficiency | | details | Urine | Detected and Quantified | 6.869 +/- 2.756 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Hypertension (mild) | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Hypertension (mild) | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details | Urine | Detected and Quantified | 0.2-0.4 umol/mmol creatinine | Adult (>18 years old) | Male | Brunner Syndrome | | details | Urine | Detected and Quantified | 0.5 umol/mmol creatinine | Children (1-13 years old) | Female | Aromatic L-amino acid decarboxylase deficiency | | details | Urine | Detected and Quantified | 0.9 umol/mmol creatinine | Infant (0-1 year old) | Female | Aromatic L-amino acid decarboxylase deficiency | | details | Urine | Detected and Quantified | 15.404 +/- 14.833 umol/mmol creatinine | Children (1-13 years old) | Both | Phenylketonuria | | details | Urine | Detected and Quantified | 4.564 +/- 1.369 umol/mmol creatinine | Children (1-13 years old) | Both | Phenylketonuria | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Aromatic L-amino acid decarboxylase deficiency |
---|
- Abdenur JE, Abeling N, Specola N, Jorge L, Schenone AB, van Cruchten AC, Chamoles NA: Aromatic l-aminoacid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis. Mol Genet Metab. 2006 Jan;87(1):48-53. Epub 2005 Nov 9. [PubMed:16288991 ]
- Abeling NG, van Gennip AH, Barth PG, van Cruchten A, Westra M, Wijburg FA: Aromatic L-amino acid decarboxylase deficiency: a new case with a mild clinical presentation and unexpected laboratory findings. J Inherit Metab Dis. 1998 Jun;21(3):240-2. [PubMed:9686366 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Phenylketonuria |
---|
- Rampini S, Vollmin JA, Bosshard HR, Muller M, Curtius HC: Aromatic acids in urine of healthy infants, persistent hyperphenylalaninemia, and phenylketonuria, before and after phenylalanine load. Pediatr Res. 1974 Jul;8(7):704-9. [PubMed:4837567 ]
| Brunner Syndrome |
---|
- Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC, Kuiper MA, Ropers HH, van Oost BA: X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993 Jun;52(6):1032-9. [PubMed:8503438 ]
|
|
---|
Associated OMIM IDs | - 114500 (Colorectal cancer)
- 608643 (Aromatic L-amino acid decarboxylase deficiency)
- 610247 (Eosinophilic esophagitis)
- 261600 (Phenylketonuria)
- 300615 (Brunner Syndrome)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB021931 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 643307 |
---|
KEGG Compound ID | C05584 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | 46071 |
---|
Wikipedia Link | Vanillylmandelic acid |
---|
METLIN ID | 697 |
---|
PubChem Compound | 736172 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 1127735 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | 3MOX4HOXM |
---|
MarkerDB ID | MDB00000136 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Recondo, E. F.; Rinderknecht, H. Preparation of epinephrine and norepinephrine metabolites, 3-methoxy-4-hydroxymandelic acid and 3,4-dihydroxymandelic acid. Journal of Organic Chemistry (1960), 25 2248-50. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Guneral F, Bachmann C: Age-related reference values for urinary organic acids in a healthy Turkish pediatric population. Clin Chem. 1994 Jun;40(6):862-6. [PubMed:8087979 ]
- Raw I, Schmidt BJ, Merzel J: Catecholamines and congenital pain insensitivity. Braz J Med Biol Res. 1984;17(3-4):271-9. [PubMed:6085021 ]
- Goldstein DS, Eisenhofer G, Kopin IJ: Sources and significance of plasma levels of catechols and their metabolites in humans. J Pharmacol Exp Ther. 2003 Jun;305(3):800-11. Epub 2003 Mar 20. [PubMed:12649306 ]
- Silbergeld EK, Chisolm JJ Jr: Lead poisoning: altered urinary catecholamine metabolites as indicators of intoxication in mice and children. Science. 1976 Apr 9;192(4235):153-5. [PubMed:1257763 ]
- Frank K, Raue F, Gottswinter J, Heinrich U, Meybier H, Ziegler R: Importance of early diagnosis and follow-up in multiple endocrine neoplasia (MEN II B). Eur J Pediatr. 1984 Dec;143(2):112-6. [PubMed:6394335 ]
- Takahashi S, Godse DD, Warsh JJ, Stancer HC: A gas chromatographic-mass spectrometric (GC-MS) assay for 3-methoxy-4-hydroxyphenethyleneglycol and vanilmandelic acid in human serum. Clin Chim Acta. 1977 Dec 1;81(2):182-92. [PubMed:589798 ]
- Suga K, Shimizu K, Nishigauchi K, Kume N, Kawamura T, Matsunaga N: [A case of bilateral adrenal neuroblastomas detected by bone scintigraphy]. Kaku Igaku. 1996 Dec;33(12):1337-42. [PubMed:9023440 ]
- Hartleb J, Eue S, Kemper A: Simultaneous analysis of homovanillic acid, 5-hydroxyindoleacetic acid, 3-methoxy-4-hydroxyphenylethylene glycol and vanilmandelic acid in plasma from alcoholics by high-performance liquid chromatography with electrochemical detection. Critical comparison of solid-phase and liquid-liquid extraction methods. J Chromatogr. 1993 Dec 22;622(2):161-71. [PubMed:7512090 ]
- Dias PL, Amarasiri AA: 4-hydroxy-3-methoxymandelic acid (HMMA) excretion in retinoblastoma. Br J Ophthalmol. 1978 Aug;62(8):525-7. [PubMed:687548 ]
- Saran RK, Sahuja RC, Gupta NN, Hasan M, Bhargava KP, Shanker K, Kishor K: 3-Methoxy-4-hydroxyphenylglycol in cerebrospinal fluid and vanillylmandelic acid in urine of humans with hypertension. Science. 1978 Apr 21;200(4339):317-8. [PubMed:635588 ]
- Strittmatter M, Grauer M, Isenberg E, Hamann G, Fischer C, Hoffmann KH, Blaes F, Schimrigk K: Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia. Headache. 1997 Apr;37(4):211-6. [PubMed:9150615 ]
- Zambotti F, Blau K, King GS, Campbell S, Sandler M: Monoamine metabolites and related compounds in human amniotic fluid: assay by gas chromatography and gas chromatography-mass spectrometry. Clin Chim Acta. 1975 Jun 20;61(3):247-56. [PubMed:1149252 ]
- Drebing CJ, Freedman R, Waldo M, Gerhardt GA: Unconjugated methoxylated catecholamine metabolites in human saliva. Quantitation methodology and comparison with plasma levels. Biomed Chromatogr. 1989 Sep;3(5):217-20. [PubMed:2804429 ]
- Bostrom B, Mirkin BL: Elevation of cerebrospinal fluid catecholamine metabolites in patients with intracranial tumors of neuroectodermal origin. J Clin Oncol. 1987 Jul;5(7):1090-7. [PubMed:3598613 ]
- Afonso D, Castellanos MA, Rodriguez M: Determination of monoamines and indoles in amniotic fluid by high-performance liquid chromatography-electrochemical detection. J Chromatogr. 1990 Jun 8;528(1):101-9. [PubMed:1696583 ]
- Djoumbou-Feunang Y, Fiamoncini J, Gil-de-la-Fuente A, Greiner R, Manach C, Wishart DS: BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform. 2019 Jan 5;11(1):2. doi: 10.1186/s13321-018-0324-5. [PubMed:30612223 ]
|
---|